Education and Reminders for Lung Cancer Screening
Trial Summary
What is the purpose of this trial?
The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on lung cancer screening and education, so it's unlikely that you would need to change your medications, but you should confirm with the trial coordinators.
What data supports the effectiveness of the treatment Empower Latinx for lung cancer screening?
The study on a cancer education-plus-navigation intervention showed that using community health workers to provide education and guidance significantly increased cancer screening rates among Latinos. This suggests that similar educational and navigational strategies, like those potentially used in Empower Latinx, could effectively improve lung cancer screening participation.12345
Is the Education and Reminders for Lung Cancer Screening program safe for humans?
How does the Empower Latinx treatment for lung cancer screening differ from other treatments?
The Empower Latinx treatment is unique because it focuses on culturally tailored education and reminders specifically for the Latinx community to increase awareness and participation in lung cancer screening, unlike standard treatments that may not address cultural and community-specific barriers.458910
Research Team
Gelareh Sadigh, MD
Principal Investigator
University of California, Irvine
Eligibility Criteria
This trial is for Hispanic individuals aged 50-80 who are current or former smokers (quit within the last 15 years) with a history of heavy smoking. They must have an upcoming primary care appointment and be able to speak English or Spanish. It's focused on those in Orange County attending UCI Health clinics.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-level intervention including PCP notifications, education, financial navigation resources, and reminders to discuss LCS during PCP visits
Follow-up
Participants are monitored for changes in knowledge, perceived benefits, barriers, self-efficacy, risk, and severity of lung cancer screening
Qualitative Assessment
Patient and provider experiences with the intervention are assessed through qualitative interviews
Treatment Details
Interventions
- Empower Latinx
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
Radiological Society of North America
Collaborator